DCGI grants EUA to Corbevax for these aged 5-12, Covaxin for 6-12 age group

By PTI

NEW DELHI: India’s drug regulator has granted emergency use authorisation for Biological E’s COVID-19 vaccine Corbevax for these aged 5 to 12 years and Bharat Biotech’s Covaxin for youngsters within the age group of six to 12 years, official sources mentioned on Tuesday.

The approval by the Drugs Controller General of India (DCGI) comes following suggestions by the Subject Expert Committee (SEC) on COVID-19 of the Central Drugs Standard Control Organisation(CDSCO).

The SEC had final week reviewed the applying of each the businesses looking for emergency use authorisation for Corbevax and Covaxin to be used in kids of 5 to 12 years and 6 to 12 years age group, respectively.

Biological E’s Corbevax is getting used to inoculate kids in opposition to COVID-19 within the age group of 12 to 14 years.

Covaxin has been granted Emergency Use Listing (EUL) by the DCGI for the age group of 12 to 18 years on December 24, 2021. India started inoculating kids aged 12-14 on March 16.

The countrywide vaccination drive was rolled out on January 16 final 12 months with healthcare staff getting inoculated within the first section. Vaccination of frontline staff began from February 2 final 12 months.

The subsequent section of COVID-19 vaccination commenced on March 1 final 12 months for individuals over 60 years of age and people aged 45 and above with specified co-morbid situations. India launched vaccination for all individuals aged greater than 45 years from April 1 final 12 months.

The authorities then determined to develop its vaccination drive by permitting everybody above 18 years of age to be inoculated in opposition to the viral illness from May 1 final 12 months. The subsequent section of vaccination commenced on January 3 for adolescents within the age group of 15-18 years.

India started administering precaution doses of vaccines to healthcare and frontline staff and people aged 60 and above with comorbidities from January 10. Precaution doses of COVID-19 vaccines to all aged above 18 years have been allowed at non-public vaccination centres from April 10.